Calorie restriction protects against acute systemic LPS-induced inflammation

被引:2
作者
da Silva, Vanessa-Fernanda [1 ]
Gayger-Dias, Vitor [1 ]
da Silva, Rafaela Sampaio [1 ]
Sobottka, Thomas Michel [1 ]
Cigerce, Anderson [1 ]
Lissner, Lilian Juliana [1 ,2 ]
Wartchow, Krista Mineia [3 ]
Rodrigues, Leticia [1 ]
Zanotto, Caroline [4 ]
Froes, Fernanda Carolina Telles da Silva [1 ]
Seady, Marina [1 ]
Quincozes-Santos, Andre [1 ]
Goncalves, Carlos-Alberto [1 ,5 ]
机构
[1] Univ Fed Rio Grande do Sul UFRGS, Grad Program Biochem, Inst Ciencias Bas Saude ICBS, Porto Alegre, Brazil
[2] Univ Roma La Sapienza, Dipartimento Fisiol & Farmacol Vittorio Erspamer, Rome, Italy
[3] Weill Cornell Med, Brain Hlth Imaging Inst, Dept Radiol, New York, NY USA
[4] Grp Hosp Conceicao, Biochem Lab, Porto Alegre, Brazil
[5] Programa Posgrad Bioquim, Ramiro Barcelos 2600, BR-90035003 Porto Alegre, RS, Brazil
关键词
Astrocyte; caloric restriction; inflammation; GFAP; Hippocampus; LPS; microglia; neuroprotection; LIPOPOLYSACCHARIDE; HIPPOCAMPUS; GLUTATHIONE; ACTIVATION; DISEASE; CORTEX; AGE;
D O I
10.1080/1028415X.2024.2316448
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Caloric restriction (CR) has been proposed as a nutritional strategy to combat chronic diseases, including neurodegenerative diseases, as well as to delay aging. However, despite the benefits of CR, questions remain about its underlying mechanisms and cellular and molecular targets.Objective: As inflammatory processes are the basis or accompany chronic diseases and aging, we investigated the protective role of CR in the event of an acute inflammatory stimulus.Methods: Peripheral inflammatory and metabolic parameters were evaluated in Wistar rats following CR and/or acute lipopolysaccharide (LPS) administration, as well as glial changes (microglia and astrocytes), in two regions of the brain (hippocampus and hypothalamus) involved in the inflammatory response. We used a protocol of 30% CR, for 4 or 8 weeks. Serum and brain parameters were analyzed by biochemical or immunological assays.Results: Benefits of CR were observed during the inflammatory challenge, where the partial reduction of serum interleukin-6, mediated by CR, attenuated the systemic response. In the central nervous system (CNS), specifically in the hippocampus, CR attenuated the response to the LPS, as evaluated by tumor necrosis factor alpha (TNF alpha) levels. Furthermore, in the hippocampus, CR increased the glutathione (GSH) levels, resulting in a better antioxidant response.Discussion: This study contributes to the understanding of the effects of CR, particularly in the CNS, and expands knowledge about glial cells, emphasizing their importance in neuroprotection strategies.
引用
收藏
页码:1237 / 1249
页数:13
相关论文
共 50 条
  • [41] A dual role of 12/15-lipoxygenase in LPS-induced acute renal inflammation and injury
    Elmarakby, Ahmed A.
    Ibrahim, Ahmed S.
    Katary, Mohamed A.
    Elsherbiny, Nehal M.
    El-Shafey, Mohamed
    Abd-Elrazik, Ahmed M.
    Abdelsayed, Rafik A.
    Maddipati, Krishna Rao
    Al-Shabrawey, Mohamed
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2019, 1864 (11): : 1669 - 1680
  • [42] An antibody to IL-1 receptor 7 protects mice from LPS-induced tissue and systemic inflammation
    Jiang, Liqiong
    Lunding, Lars P.
    Webber, William S.
    Beckmann, Karsten
    Azam, Tania
    Hojen, Jesper Falkesgaard
    Amo-Aparicio, Jesus
    Dinarello, Alberto
    Nguyen, Tom T.
    Pessara, Ulrich
    Parera, Daniel
    Orlicky, David J.
    Fischer, Stephan
    Wegmann, Michael
    Dinarello, Charles A.
    Li, Suzhao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] Protective effect of Apremilast against LPS-induced acute lung injury via modulation of oxidative stress and inflammation
    Al-Harbi, Naif O.
    Imam, Faisal
    Al-Harbi, Mohammad Matar
    Aljeryan, Khaldoon
    Al-Shabanah, Othman A.
    Alhosaini, Khaled A.
    Alqahtani, Lamya Saif
    Afzal, Muhammad
    Anwer, M. D. Khalid
    Aldossari, Abdullah A.
    Alanazi, Mohammed M.
    Alsanea, Sary
    Assiri, Mohammed A.
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (05) : 3414 - 3424
  • [44] Sirt1 Protects Endothelial Cells against LPS-Induced Barrier Dysfunction
    Zhang, Weijin
    Zhang, Yaoyuan
    Guo, Xiaohua
    Zeng, Zhenhua
    Wu, Jie
    Liu, Yanan
    He, Jing
    Wang, Ruiting
    Huang, Qiaobing
    Chen, Zhongqing
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [45] p53 protects against LPS-induced lung endothelial barrier dysfunction
    Barabutis, Nektarios
    Dimitropoulou, Christiana
    Birmpas, Charalampos
    Joshi, Atul
    Thangjam, Gagan
    Catravas, John D.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2015, 308 (08) : L776 - L787
  • [46] Morphine Preconditioning Protects Against LPS-Induced Neuroinflammation and Memory Deficit
    Farzaneh Rostami
    Shahrbanoo Oryan
    Abolhassan Ahmadiani
    Leila Dargahi
    Journal of Molecular Neuroscience, 2012, 48 : 22 - 34
  • [47] Sesamol protects against LPS-induced inflammation in rat peritoneal macrophages by promoting SIRT1-induced repression of NF-κB
    Sakunthala, Aparna Nandakumaran
    Sreedevi, Aswani Sukumaran
    Mohan, Mithra Sudha
    Thankappan, Boban Puthenpura
    Kamalamma, Saja
    PHYSIOLOGY INTERNATIONAL, 2025, 111 (04) : 321 - 338
  • [48] Morphine Preconditioning Protects Against LPS-Induced Neuroinflammation and Memory Deficit
    Rostami, Farzaneh
    Oryan, Shahrbanoo
    Ahmadiani, Abolhassan
    Dargahi, Leila
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 (01) : 22 - 34
  • [49] Recombinant chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS) protects against LPS-induced lung injury in mice
    Ali, Youssif M.
    Abd El-Aziz, Abeer M.
    Mabrook, Maha
    Shabaan, Ahmed A.
    Sim, Robert B.
    Hassan, Ramadan
    CLINICAL IMMUNOLOGY, 2018, 197 : 27 - 33
  • [50] Nur77-mediated TRAF6 signalling protects against LPS-induced sepsis in mice
    Li, Xiu-Ming
    Zhang, Shen
    He, Xiao-Shun
    Guo, Peng-Da
    Lu, Xing-Xing
    Wang, Jing-Ru
    Li, Jian-Ming
    Wu, Hua
    JOURNAL OF INFLAMMATION-LONDON, 2016, 13